Journal Article

The role of nitric oxide in neoplastic transformation of C3H 10T1/2 embryonic fibroblasts

Terrilea Burnett, Ao Pung, John S. Bertram and Robert V. Cooney

in Carcinogenesis

Volume 21, issue 11, pages 1989-1995
Published in print November 2000 | ISSN: 0143-3334
Published online November 2000 | e-ISSN: 1460-2180 | DOI: https://dx.doi.org/10.1093/carcin/21.11.1989
The role of nitric oxide in neoplastic transformation of C3H 10T1/2 embryonic fibroblasts

More Like This

Show all results sharing this subject:

  • Clinical Cytogenetics and Molecular Genetics

GO

Show Summary Details

Preview

Nitric oxide synthase inhibitors block the neoplastic transformation of C3H 10T1/2 cells in vitro. Evidence presented herein suggests that they mediate their effects early in the carcinogenic process as brief treatment with the NOS inhibitor aminoguanidine (AG) during log phase cell growth (initiation phase) is sufficient to block foci formation. In contrast, treatment initiated after formation of a confluent monolayer was associated with diminished protection, while treatment commencing late in the promotional phase had no protective effect and appeared to enhance the number and stage of foci observed. These findings suggest that while AG treatment can inhibit transformation during the early promotional phase, it most effectively inhibits transformation during the initiation phase. In general AG enhanced growth of both normal and tumor cells, suggesting that effects on growth were unrelated to its anti-transformation properties, however, these effects could be related to the effect on tumor cell stage noted above. Although induction of inducible nitric oxide synthase (iNOS) by treatment with LI during the last 2 weeks of the assay was associated with enhanced transformation, the efficacy of AG in protecting against transformation was not clearly associated with substantial reductions in NO synthesis. The data suggest that AG inhibits transformation early in the transformation process independently of iNOS inhibition and that AG may have deleterious effects late in the process, possibly through stimulation of tumor cell growth.

Keywords: AG, aminoguanidine; BME, Eagle's basal medium; DAN, 2,3-diaminonaphthalene; IFN-γ, γ-interferon; iNOS, inducible nitric oxide synthase; LI, lipopolysaccharide plus γ-interferon; LPS, lipopolysaccharide; MCA, 3-methylcholanthrene; MF, mutation frequency; MNNG, N-methyl-N′-nitro-N-nitrosoguanidine; NAT, 2,3-naphthatriazole; NOx, nitrogen oxides; PBS, phosphate-buffered saline; PE, plating efficiency; ROS, reactive oxygen species.

Journal Article.  6100 words.  Illustrated.

Subjects: Clinical Cytogenetics and Molecular Genetics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.